Seres Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $300k | 317k | 0.95 |
| 2024-06-30 | $166k | 230k | 0.72 |
| 2024-03-31 | $171k | 221k | 0.77 |
| 2023-12-31 | $193k | 138k | 1.40 |
| 2023-09-30 | $864k | 363k | 2.38 |
| 2023-06-30 | $1.9M | 401k | 4.79 |
| 2023-03-31 | $3.7M | 658k | 5.67 |
| 2022-12-31 | $450k | 80k | 5.60 |
| 2022-06-30 | $712k | 208k | 3.43 |
| 2022-03-31 | $2.2M | 304k | 7.12 |
| 2021-12-31 | $4.2M | 504k | 8.33 |
| 2021-09-30 | $1.5M | 216k | 6.96 |
| 2021-06-30 | $9.4M | 395k | 23.86 |
| 2021-03-31 | $8.8M | 429k | 20.60 |
| 2020-12-31 | $8.2M | 336k | 24.51 |
| 2020-09-30 | $3.2M | 114k | 28.31 |
| 2020-06-30 | $666k | 140k | 4.76 |
| 2020-03-31 | $161k | 45k | 3.56 |
| 2019-12-31 | $168k | 49k | 3.45 |
| 2019-09-30 | $72k | 18k | 4.02 |
| 2019-06-30 | $213k | 66k | 3.24 |
| 2019-03-31 | $109k | 16k | 6.87 |
| 2018-12-31 | $200k | 44k | 4.51 |
| 2018-09-30 | $239k | 31k | 7.62 |
| 2018-06-30 | $183k | 21k | 8.63 |
| 2018-03-31 | $1.0M | 137k | 7.33 |
| 2017-12-31 | $1.4M | 138k | 10.14 |
| 2017-06-30 | $456k | 40k | 11.33 |
| 2017-03-31 | $233k | 21k | 11.28 |
| 2016-12-31 | $117k | 12k | 9.90 |
| 2016-09-30 | $1.5M | 123k | 12.28 |